Each row is a drug, each column a cancer subtype. Cells show the strongest known association for that drug in that cancer: approved clinical trial or blank. The repositionable flag means the drug appears as a synthetic-lethal repositioning candidate in cansar; it’s gene-level, not cancer-level.
| Drug | Target | Relationship | GBM | LUAD | SCLC | LUSC | OAC | OSCC | PDAC | Reposition | #cancers |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ascorbic acid, paclitaxel protein-bound, cisplatin, gemcitabine | DBH | Direct | 1 | ||||||||
| chemotherapy, disulfiram, gemcitabine hydrochloride, laboratory biomarker analysis | DBH | Direct | 1 | ||||||||
| disulfiram, copper gluconate, surgery, radiation, temozolomide | DBH | Direct | 1 | ||||||||
| disulfiram, copper, alkylating agents | DBH | Direct | 1 | ||||||||
| oxaliplatin, irinotecan hydrochloride, leucovorin calcium, fluorouracil, ascorbic acid | DBH | Direct | 1 | ||||||||
| temozolomide, aprepitant, minocycline, disulfiram, celecoxib, sertraline, captopril, itraconazole, ritonavir, auranofin | DBH | Direct | 1 | ||||||||
| temozolomide, disulfiram, copper gluconate | DBH | Direct | 1 | ||||||||
| temozolomide, radiation therapy, ascorbic acid | DBH | Direct | 1 | ||||||||
| adavosertib, afatinib, afatinib dimaleate, binimetinib, biopsy, biospecimen collection, capivasertib, computed tomography, copanlisib, copanlisib hydrochloride, crizotinib, cytology specimen collection procedure, dabrafenib, dabrafenib mesylate, dasatinib, defactinib, defactinib hydrochloride, echocardiography, erdafitinib, fexagratinib, ipatasertib, laboratory biomarker analysis, larotrectinib, larotrectinib sulfate, magnetic resonance imaging, multigated acquisition scan, nivolumab, osimertinib, palbociclib, pertuzumab, pi3k-beta inhibitor gsk2636771, radiologic examination, radionuclide imaging, relatlimab, sapanisertib, sunitinib malate, taselisib, trametinib, trastuzumab, trastuzumab emtansine, ulixertinib, vismodegib | ALK | SSL via ALK | 3 | ||||||||
| adavosertib, afatinib, afatinib dimaleate, binimetinib, biopsy, biospecimen collection, capivasertib, computed tomography, copanlisib, copanlisib hydrochloride, crizotinib, cytology specimen collection procedure, dabrafenib, dabrafenib mesylate, dasatinib, defactinib, defactinib hydrochloride, echocardiography, erdafitinib, fexagratinib, ipatasertib, laboratory biomarker analysis, larotrectinib, larotrectinib sulfate, magnetic resonance imaging, multigated acquisition scan, nivolumab, osimertinib, palbociclib, pertuzumab, pi3k-beta inhibitor gsk2636771, radiologic examination, radionuclide imaging, relatlimab, sapanisertib, sunitinib malate, taselisib, trametinib, trastuzumab, trastuzumab emtansine, ulixertinib, vismodegib | FGFR3 | SSL via FGFR3 | 3 | ||||||||
| adavosertib, afatinib, afatinib dimaleate, binimetinib, biopsy, biospecimen collection, capivasertib, computed tomography, copanlisib, copanlisib hydrochloride, crizotinib, cytology specimen collection procedure, dabrafenib, dabrafenib mesylate, dasatinib, defactinib, defactinib hydrochloride, echocardiography, erdafitinib, fexagratinib, ipatasertib, laboratory biomarker analysis, larotrectinib, larotrectinib sulfate, magnetic resonance imaging, multigated acquisition scan, nivolumab, osimertinib, palbociclib, pertuzumab, pi3k-beta inhibitor gsk2636771, radiologic examination, radionuclide imaging, relatlimab, sapanisertib, sunitinib malate, taselisib, trametinib, trastuzumab, trastuzumab emtansine, ulixertinib, vismodegib | PIK3CD | SSL via PIK3CD | 3 | ||||||||
| crizotinib | ALK | SSL via ALK | yes | 3 | |||||||
| futibatinib, pembrolizumab, cisplatin, 5-fu, oxaliplatin, leucovorin, levoleucovorin, irinotecan | FGFR3 | SSL via FGFR3 | 3 | ||||||||
| futibatinib, pembrolizumab, cisplatin, 5-fu, oxaliplatin, leucovorin, levoleucovorin, irinotecan | TOP1 | SSL via TOP1 | 3 | ||||||||
| lurbinectedin, irinotecan | TOP1 | SSL via TOP1 | 3 | ||||||||
| pembrolizumab, belzutifan, lenvatinib | FGFR3 | SSL via FGFR3 | 3 | ||||||||
| alectinib, brigatinib, lorlatinib 100 mg, osimertinib, sotorasib, dabrafenib, trametinib, selpercatinib, pembrolizumab, cemiplimab, nivolumab, carboplatin, pemetrexed, paclitaxel | ALK | SSL via ALK | 2 | ||||||||
| alectinib, brigatinib, lorlatinib 100 mg, osimertinib, sotorasib, dabrafenib, trametinib, selpercatinib, pembrolizumab, cemiplimab, nivolumab, carboplatin, pemetrexed, paclitaxel | FGFR3 | SSL via FGFR3 | 2 | ||||||||
| alectinib, stereotactic radiosurgery | ALK | SSL via ALK | 2 | ||||||||
| apatinib, irinotecan | TOP1 | SSL via TOP1 | 2 | ||||||||
| asp2138, pembrolizumab, oxaliplatin, leucovorin, fluorouracil, ramucirumab, paclitaxel, irinotecan | TOP1 | SSL via TOP1 | 2 | ||||||||
| asp3082, cetuximab, leucovorin, oxaplatin, fluorouracil, irinotecan, nanoparticle albumin-bound-paclitaxel, gemcitabine | TOP1 | SSL via TOP1 | 2 | ||||||||
| bbi-355, erlotinib, futibatinib | FGFR3 | SSL via FGFR3 | 2 | ||||||||
| bryostatin 1, paclitaxel | PRKCA | SSL via PRKCA | 2 | ||||||||
| cetuximab, cisplatin, irinotecan, radiation therapy, surgery | TOP1 | SSL via TOP1 | 2 | ||||||||
| entrectinib, entrectinib, alectinib, atezolizumab, ipatasertib, trastuzumab emtansine, idasanutlin, inavolisib, belvarafenib, pralsetinib, gdc-6036, camonsertib | ALK | SSL via ALK | 2 | ||||||||
| gi-101, pembrolizumab (keytruda®), lenvatinib, local radiotherapy, gi-101a | FGFR3 | SSL via FGFR3 | 2 | ||||||||
| inbrx-109, carboplatin, cisplatin, pemetrexed, 5-fluorouracil, irinotecan, temozolomide | TOP1 | SSL via TOP1 | 2 | ||||||||
| irinotecan, capecitabine | TOP1 | SSL via TOP1 | 2 | ||||||||
| irinotecan, docetaxel | TOP1 | SSL via TOP1 | 2 | ||||||||
| lenvatinib, pembrolizumab | FGFR3 | SSL via FGFR3 | 2 | ||||||||
| lenvatinib, pembrolizumab, hyperpolarized 13c-pyruvate | FGFR3 | SSL via FGFR3 | 2 | ||||||||
| ly4066434., cetuximab, nab paclitaxel, gemcitabine, oxaliplatin, leucovorin, irinotecan, 5fluorouracil, carboplatin, cisplatin, pemetrexed, pembrolizumab | TOP1 | SSL via TOP1 | 2 | ||||||||
| mk-4830, pembrolizumab, carboplatin, pemetrexed, lenvatinib, paclitaxel, cisplatin, mk-4830a | FGFR3 | SSL via FGFR3 | 2 | ||||||||
| nintedanib | FGFR3 | SSL via FGFR3 | yes | 2 | |||||||
| nintedanib, pembrolizumab | FGFR3 | SSL via FGFR3 | 2 | ||||||||
| pazopanib | FGFR3 | SSL via FGFR3 | yes | 2 | |||||||
| pembrolizumab, lenvatinib | FGFR3 | SSL via FGFR3 | 2 | ||||||||
| pembrolizumab, lenvatinib, oxaliplatin, capecitabine, leucovorin (or levoleucovorin), 5-fu | FGFR3 | SSL via FGFR3 | 2 | ||||||||
| pembrolizumab, paclitaxel, docetaxel, irinotecan | TOP1 | SSL via TOP1 | 2 | ||||||||
| pembrolizumab/vibostolimab co-formulation, pembrolizumab, lenvatinib, 5-fluorouracil, cisplatin, paclitaxel, gemcitabine, carboplatin, docetaxel, bevacizumab, capecitabine, oxaliplatin | FGFR3 | SSL via FGFR3 | 2 | ||||||||
| quality-of-life assessment, questionnaire administration, selpercatinib, therapeutic conventional surgery | FGFR3 | SSL via FGFR3 | 2 | ||||||||
| rubitecan | TOP1 | SSL via TOP1 | 2 | ||||||||
| sacituzumab govitecan | TOP1 | SSL via TOP1 | yes | 2 | |||||||
| topotecan | TOP1 | SSL via TOP1 | yes | 2 | |||||||
| trastuzumab deruxtecan | TOP1 | SSL via TOP1 | yes | 2 | |||||||
| 5 fluorouracil, leucovorin, irinotecan, oxaliplatin | TOP1 | SSL via TOP1 | 1 | ||||||||
| 9-ing-41, gemcitabine - 21 day cycle, doxorubicin., lomustine, carboplatin., nab paclitaxel., paclitaxel., gemcitabine - 28 day cycle, irinotecan | TOP1 | SSL via TOP1 | 1 | ||||||||
| abemaciclib, irinotecan, temozolomide, dinutuximab, gm-csf | TOP1 | SSL via TOP1 | 1 | ||||||||
| afatinib, irinotecan | TOP1 | SSL via TOP1 | 1 | ||||||||
| aldoxorubicin, topotecan | TOP1 | SSL via TOP1 | 1 | ||||||||
| amrubicin, topotecan | TOP1 | SSL via TOP1 | 1 | ||||||||
| andecaliximab, gemcitabine, nab-paclitaxel, carboplatin, pemetrexed, leucovorin, oxaliplatin, 5-fu, bevacizumab, irinotecan, paclitaxel | TOP1 | SSL via TOP1 | 1 | ||||||||
| apg101, alectinib, idasanutlin, atezolizumab, vismodegib, temsirolimus, palbociclib | ALK | SSL via ALK | 1 | ||||||||
| at-101, topotecan | TOP1 | SSL via TOP1 | 1 | ||||||||
| avastin, temozolomide, irinotecan | TOP1 | SSL via TOP1 | 1 | ||||||||
| avastin, temozolomide, radiation therapy (xrt), irinotecan | TOP1 | SSL via TOP1 | 1 | ||||||||
| avelumab, irinotecan, paclitaxel, best supportive care (bsc) | TOP1 | SSL via TOP1 | 1 | ||||||||
| azd0901, 5-fluorouracil, leucovorin, l-leucovorin, irinotecan, nanoliposomal irinotecan, gemcitabine | TOP1 | SSL via TOP1 | 1 | ||||||||
| azenosertib, biopsy, biospecimen collection, computed tomography, echocardiography, magnetic resonance imaging, multigated acquisition scan, trastuzumab deruxtecan | TOP1 | SSL via TOP1 | 1 | ||||||||
| bbi608, nab-paclitaxel, gemcitabine, oxaliplatin, leucovorin, irinotecan, fluorouracil, mm-398 | TOP1 | SSL via TOP1 | 1 | ||||||||
| bemarituzumab, paclitaxel, ramucirumab, bemarituzumab, irinotecan, bemarituzumab, trifluridine/tipiracil | TOP1 | SSL via TOP1 | 1 | ||||||||
| berzosertib, computed tomography assisted biopsy, endoscopic biopsy, irinotecan, magnetic resonance imaging | TOP1 | SSL via TOP1 | 1 | ||||||||
| berzosertib, sacituzumab govitecan | TOP1 | SSL via TOP1 | 1 | ||||||||
| bevacizumab [avastin], irinotecan, temozolomide | TOP1 | SSL via TOP1 | 1 | ||||||||
| bevacizumab, irinotecan | TOP1 | SSL via TOP1 | 1 | ||||||||
| bevacizumab, irinotecan, dynamic contrast-enhanced magnetic resonance imaging | TOP1 | SSL via TOP1 | 1 | ||||||||
| bevacizumab, temozolomide, radiation therapy (xrt), topotecan | TOP1 | SSL via TOP1 | 1 | ||||||||
| bi 764532, topotecan, single agent chemotherapy | TOP1 | SSL via TOP1 | 1 | ||||||||
| biopsy, biospecimen collection, ceralasertib, computed tomography, echocardiography, multigated acquisition scan, positron emission tomography, trastuzumab deruxtecan | TOP1 | SSL via TOP1 | 1 | ||||||||
| biopsy, biospecimen collection, computed tomography, copanlisib, magnetic resonance imaging | PIK3CD | SSL via PIK3CD | 1 | ||||||||
| biopsy, biospecimen collection, computed tomography, endoscopic ultrasound, fluorouracil, irinotecan, leucovorin, lymph node biopsy, magnetic resonance imaging, oxaliplatin, pembrolizumab, photodynamic therapy, positron emission tomography, questionnaire administration, verteporfin | TOP1 | SSL via TOP1 | 1 | ||||||||
| biopsy, biospecimen collection, computed tomography, erdafitinib, magnetic resonance imaging | FGFR3 | SSL via FGFR3 | 1 | ||||||||
| biopsy, biospecimen collection, copanlisib, radiologic examination | PIK3CD | SSL via PIK3CD | 1 | ||||||||
| biopsy, biospecimen collection, crizotinib, radiologic examination | ALK | SSL via ALK | 1 | ||||||||
| biospecimen collection, computed tomography, core biopsy, fluorouracil, irinotecan, leucovorin, leucovorin calcium, oxaliplatin, quemliclustat, zimberelimab | TOP1 | SSL via TOP1 | 1 | ||||||||
| biospecimen collection, erdafitinib, magnetic resonance imaging, optical coherence tomography | FGFR3 | SSL via FGFR3 | 1 | ||||||||
| bl-b01d1, irinotecan, paclitaxel, docetaxel | TOP1 | SSL via TOP1 | 1 | ||||||||
| bl-b01d1, topotecan | TOP1 | SSL via TOP1 | 1 | ||||||||
| bnt327 dose level 1 (dl1), bnt327 dose level 2 (dl2), etoposide, carboplatin, paclitaxel, topotecan | TOP1 | SSL via TOP1 | 1 | ||||||||
| bortezomib, irinotecan | TOP1 | SSL via TOP1 | 1 | ||||||||
| byl719, poziotinib, nintedanib, abemaciclib, durvalumab,tremelimumab | FGFR3 | SSL via FGFR3 | 1 | ||||||||
| camrelizumab, docetaxel, irinotecan | TOP1 | SSL via TOP1 | 1 | ||||||||
| camrelizumab, irinotecan, paclitaxel, paclitaxel-albumin, docetaxel, anlotinib | TOP1 | SSL via TOP1 | 1 | ||||||||
| capecitabine, oxaliplatin, irinotecan | TOP1 | SSL via TOP1 | 1 | ||||||||
| carboplatin, irinotecan | TOP1 | SSL via TOP1 | 1 | ||||||||
| carboxylesterase-expressing allogeneic neural stem cells, irinotecan, irinotecan hydrochloride, laboratory biomarker analysis, pharmacological study | TOP1 | SSL via TOP1 | 1 | ||||||||
| ceritinib, cisplatin, gemcitabine hydrochloride, laboratory biomarker analysis, paclitaxel albumin-stabilized nanoparticle formulation, pharmacological study | ALK | SSL via ALK | 1 | ||||||||
| cetuximab, bevacizumab, irinotecan | TOP1 | SSL via TOP1 | 1 | ||||||||
| cetuximab, irinotecan, oxaliplatin, uft | TOP1 | SSL via TOP1 | 1 | ||||||||
| cisplatin, fluorouracil, gemcitabine, irinotecan, leucovorin, nab-paclitaxel, oxaliplatin, radiation therapy | TOP1 | SSL via TOP1 | 1 | ||||||||
| cisplatin, gleevec™, irinotecan | TOP1 | SSL via TOP1 | 1 | ||||||||
| cisplatin, irinotecan, capecitabine | TOP1 | SSL via TOP1 | 1 | ||||||||
| cytoreductive surgery, perifosine, temsirolimus | PRKCA | SSL via PRKCA | 1 | ||||||||
| digoxin, 5fluorouracil, calcium leucovorin, irinotecan, oxaliplatin | TOP1 | SSL via TOP1 | 1 | ||||||||
| doxorubicin, cisplatin, 5-fluorouracil | TOP1 | SSL via TOP1 | 1 | ||||||||
| durvalumab, oxaliplatin, irinotecan, calcium folinate (leucovorin), fluorouracil, pegylated g-csf | TOP1 | SSL via TOP1 | 1 | ||||||||
| edotecarin, temozolomide, carmustine (bcnu), lomustine (ccnu) | TOP1 | SSL via TOP1 | 1 | ||||||||
| erdafitinib | FGFR3 | SSL via FGFR3 | yes | 1 | |||||||
| fluorouracil (5-fu), capecitabine, durvalumab, oxaliplatin, trastuzumab, trastuzumab deruxtecan, cisplatin, pembrolizumab, volrustomig, rilvegostomig | TOP1 | SSL via TOP1 | 1 |